Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gilson

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
The Practitioner|December 20, 2002
Sexual disease in male patientsJohn McSorley, Richard Gilson
Current Opinion in Infectious Diseases|November 22, 2016
Where next with preexposure prophylaxis?Diarmuid Nugent, Richard Gilson
Human Vaccines & Immunotherapeutics|December 21, 2018
Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with menAlice S Forster, Richard Gilson
Current Opinion in Infectious Diseases|December 19, 2023
Mpox in people living with HIVIrfaan Maan, Manik Kohli, Richard Gilson
BMJ Oncology|January 31, 2025
HealthCare Access Barrier (HCAB) framework for the barriers to cancer care during conflicts: perspective from IraqKouther Mohsin, Layth Mula-Hussain, Richard Gilson
Journal of the International AIDS Society|November 15, 2014
Attitudes and beliefs towards early ART initiation in MSM with primary HIV infectionVictoria Parsons, Kholoud Porter, Richard Gilson, et al.
The Lancet. Infectious Diseases|March 28, 2017
Until eradication, awarenessOliver S Jones, Claire Vassie, Richard Gilson, et al.
BMJ Open|June 8, 2019
PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in EnglandShema Tariq, Fiona M Burns, Richard Gilson, et al.
Vaccine|June 24, 2023
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trialsDavid T Dunn, Richard Gilson, Sheena McCormack, et al.
The Lancet. Infectious Diseases|February 7, 2019
Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awarenessMatt Lechner, Oliver S Jones, Charles E Breeze, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
The Practitioner|December 20, 2002
Sexual disease in male patientsJohn McSorley, Richard Gilson
Current Opinion in Infectious Diseases|November 22, 2016
Where next with preexposure prophylaxis?Diarmuid Nugent, Richard Gilson
Human Vaccines & Immunotherapeutics|December 21, 2018
Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with menAlice S Forster, Richard Gilson
Current Opinion in Infectious Diseases|December 19, 2023
Mpox in people living with HIVIrfaan Maan, Manik Kohli, Richard Gilson
BMJ Oncology|January 31, 2025
HealthCare Access Barrier (HCAB) framework for the barriers to cancer care during conflicts: perspective from IraqKouther Mohsin, Layth Mula-Hussain, Richard Gilson
Journal of the International AIDS Society|November 15, 2014
Attitudes and beliefs towards early ART initiation in MSM with primary HIV infectionVictoria Parsons, Kholoud Porter, Richard Gilson, et al.
The Lancet. Infectious Diseases|March 28, 2017
Until eradication, awarenessOliver S Jones, Claire Vassie, Richard Gilson, et al.
BMJ Open|June 8, 2019
PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in EnglandShema Tariq, Fiona M Burns, Richard Gilson, et al.
Vaccine|June 24, 2023
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trialsDavid T Dunn, Richard Gilson, Sheena McCormack, et al.
The Lancet. Infectious Diseases|February 7, 2019
Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awarenessMatt Lechner, Oliver S Jones, Charles E Breeze, et al.
Pageof 15